• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮冠状动脉介入治疗后的全因死亡率和特定病因死亡率:来自阿尔伯塔省冠心病注册结局评估项目的观察结果

Total and Cause-Specific Mortality After Percutaneous Coronary Intervention: Observations From the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease Registry.

作者信息

Tran Dat T, Barake Walid, Galbraith Diane, Norris Colleen, Knudtson Merril L, Kaul Padma, McAlister Finlay A, Sandhu Roopinder K

机构信息

Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada.

Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada.

出版信息

CJC Open. 2019 Jun 8;1(4):182-189. doi: 10.1016/j.cjco.2019.05.003. eCollection 2019 Jul.

DOI:10.1016/j.cjco.2019.05.003
PMID:32159105
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7063620/
Abstract

BACKGROUND

Patients undergoing percutaneous coronary intervention (PCI) are increasingly older and have a higher comorbidity burden. This study evaluated trends in 30-day, 1-year, and 2-year total and cause-specific mortality using a large, contemporary cohort of patients who underwent PCI in Alberta, Canada.

METHODS

We used the lberta rovincial oject for utcome ssessment in oronary eart Disease (APPROACH) registry to identify patients aged ≥ 20 years who underwent PCI between 2005 and 2013. All patients were followed until death or being censored by August 2016. Cause of death was from the Vital Statistics database and classified as cardiac or noncardiac. Multivariable logistic regression was used to calculate predicted mortality at 30 days, 1 year, and 2 years post-PCI.

RESULTS

Of the 35,602 patients who underwent PCI, 5284 (14.8%) had died. Mean (standard deviation) follow-up was 74.9 (35.1) months. Over the study period, patients were older and more likely to undergo PCI for an acute coronary syndrome indication. Thirty-day (2005: 1.3%; 2013: 3.2%; 0.001), 1-year (2005: 2.7%; 2013: 5.7%; 0.001), and 2-year (2005: 4.5%; 2013: 7.5%; 0.001) predicted mortality after PCI increased over the study period. Cardiac cause of death dominated in the short-term, but the proportion of noncardiac deaths increased as time from PCI to death increased (30 days = 11.5%, 1 year = 31.5%, 2 years = 39.6%; < 0.001).

CONCLUSIONS

In this population-based study, we found all-cause mortality at 30 days, 1 year, and 2 years after PCI increased over time. Cardiac causes of death dominate in the short-term after PCI; however, noncardiac cause becomes a major driver of mortality in the long-term.

摘要

背景

接受经皮冠状动脉介入治疗(PCI)的患者年龄越来越大,合并症负担也越来越高。本研究使用加拿大艾伯塔省一个大型当代PCI患者队列,评估了30天、1年和2年全因死亡率及特定原因死亡率的趋势。

方法

我们使用艾伯塔省冠状动脉疾病结局评估项目(APPROACH)登记处的数据,确定2005年至2013年间接受PCI的年龄≥20岁的患者。所有患者均随访至死亡或2016年8月被截尾。死亡原因来自生命统计数据库,分为心脏原因或非心脏原因。采用多变量逻辑回归计算PCI后30天、1年和2年的预测死亡率。

结果

在35602例接受PCI的患者中,5284例(14.8%)死亡。平均(标准差)随访时间为74.9(35.1)个月。在研究期间,患者年龄更大,因急性冠状动脉综合征指征接受PCI的可能性更高。PCI后30天(2005年:1.3%;2013年:3.2%;P<0.001)、1年(2005年:2.7%;2013年:5.7%;P<0.001)和2年(2005年:4.5%;2013年:7.5%;P<0.001)的预测死亡率在研究期间有所增加。心脏原因导致的死亡在短期内占主导,但从PCI到死亡的时间增加时,非心脏原因导致的死亡比例增加(30天=11.5%,1年=31.5%,2年=39.6%;P<0.001)。

结论

在这项基于人群的研究中,我们发现PCI后30天、1年和2年的全因死亡率随时间增加。心脏原因导致的死亡在PCI后短期内占主导;然而,非心脏原因在长期内成为死亡的主要驱动因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d1/7063620/81efdb85dff1/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d1/7063620/ab6c2032c1cb/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d1/7063620/88a4edc82d6e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d1/7063620/19831572ca30/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d1/7063620/81efdb85dff1/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d1/7063620/ab6c2032c1cb/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d1/7063620/88a4edc82d6e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d1/7063620/19831572ca30/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d1/7063620/81efdb85dff1/gr4.jpg

相似文献

1
Total and Cause-Specific Mortality After Percutaneous Coronary Intervention: Observations From the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease Registry.经皮冠状动脉介入治疗后的全因死亡率和特定病因死亡率:来自阿尔伯塔省冠心病注册结局评估项目的观察结果
CJC Open. 2019 Jun 8;1(4):182-189. doi: 10.1016/j.cjco.2019.05.003. eCollection 2019 Jul.
2
Trends in cause of death after percutaneous coronary intervention.经皮冠状动脉介入治疗后死亡原因的趋势。
Circulation. 2014 Mar 25;129(12):1286-94. doi: 10.1161/CIRCULATIONAHA.113.006518. Epub 2014 Feb 10.
3
Percutaneous Intervention for Myocardial Infarction After Noncardiac Surgery: Patient Characteristics and Outcomes.经皮冠状动脉介入治疗非心脏手术后心肌梗死:患者特征和结局。
J Am Coll Cardiol. 2016 Jul 26;68(4):329-38. doi: 10.1016/j.jacc.2016.03.602.
4
Association of Ticagrelor vs Clopidogrel With Major Adverse Coronary Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.替格瑞洛与氯吡格雷对行经皮冠状动脉介入治疗的急性冠状动脉综合征患者主要不良冠状动脉事件的影响。
JAMA Intern Med. 2020 Mar 1;180(3):420-428. doi: 10.1001/jamainternmed.2019.6447.
5
Causes of Mortality After Percutaneous Coronary Intervention.经皮冠状动脉介入治疗后的死亡原因
Circ Cardiovasc Qual Outcomes. 2019 May;12(5):e005355. doi: 10.1161/CIRCOUTCOMES.118.005355.
6
Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2).经皮冠状动脉介入治疗与冠状动脉旁路移植术在需要透析的终末期肾病患者中的比较(CREDO-Kyoto PCI/CABG 登记研究队列-2 的 5 年结果)。
Am J Cardiol. 2014 Aug 15;114(4):555-61. doi: 10.1016/j.amjcard.2014.05.034. Epub 2014 Jun 6.
7
Cardiac and Noncardiac Causes of Long-Term Mortality in ST-Segment-Elevation Acute Myocardial Infarction Patients Who Underwent Primary Percutaneous Coronary Intervention.接受直接经皮冠状动脉介入治疗的ST段抬高型急性心肌梗死患者长期死亡的心脏和非心脏原因
Circ Cardiovasc Qual Outcomes. 2017 Jan;10(1). doi: 10.1161/CIRCOUTCOMES.116.002790.
8
Acute coronary syndrome and stable coronary artery disease: are they so different? Long-term outcomes in a contemporary PCI cohort.急性冠状动脉综合征和稳定型冠状动脉疾病:它们有那么不同吗?当代经皮冠状动脉介入治疗队列的长期结局。
Int J Cardiol. 2013 Aug 20;167(4):1343-6. doi: 10.1016/j.ijcard.2012.04.011. Epub 2012 Apr 23.
9
Cause of death within 30 days of percutaneous coronary intervention in an era of mandatory outcome reporting.在强制性结果报告时代经皮冠状动脉介入治疗后 30 天内的死亡原因。
J Am Coll Cardiol. 2013 Jul 30;62(5):409-15. doi: 10.1016/j.jacc.2013.03.071. Epub 2013 May 9.
10
Cancer History Portends Worse Acute and Long-term Noncardiac (but Not Cardiac) Mortality After Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction.癌症病史预示着急性ST段抬高型心肌梗死直接经皮冠状动脉介入治疗后更差的急性和长期非心脏(而非心脏)死亡率。
Mayo Clin Proc. 2016 Dec;91(12):1680-1692. doi: 10.1016/j.mayocp.2016.06.029.

引用本文的文献

1
Sex Difference in 5-year Relative Survival Following Percutaneous Coronary Intervention.经皮冠状动脉介入治疗后5年相对生存率的性别差异
Eur Cardiol. 2024 Oct 2;19:e18. doi: 10.15420/ecr.2024.25. eCollection 2024.
2
Clinical Outcomes of Sickle Cell Disease Patients With Myocardial Infarction Undergoing Percutaneous Coronary Intervention: A Nationwide Analysis.镰状细胞病合并心肌梗死患者行经皮冠状动脉介入治疗的临床结局:一项全国性分析。
Cureus. 2024 Sep 15;16(9):e69465. doi: 10.7759/cureus.69465. eCollection 2024 Sep.
3
Symptomatic HIV infection and in-hospital outcomes for patients with acute myocardial infarction undergoing percutaneous coronary intervention from national inpatient sample.

本文引用的文献

1
Quality of Acute Myocardial Infarction Care in Canada: A 10-Year Review of 30-Day In-Hospital Mortality and 30-Day Hospital Readmission.加拿大急性心肌梗死治疗质量:30 天院内死亡率和 30 天内再入院率的 10 年回顾。
Can J Cardiol. 2017 Oct;33(10):1319-1326. doi: 10.1016/j.cjca.2017.06.014. Epub 2017 Jul 8.
2
A population-based study of homicide deaths in Ontario, Canada using linked death records.基于人群的加拿大安大略省 homicide 死亡研究:使用死亡记录链接。
Int J Equity Health. 2017 Jul 24;16(1):133. doi: 10.1186/s12939-017-0632-9.
3
Socioeconomic gradients in all-cause, premature and avoidable mortality among immigrants and long-term residents using linked death records in Ontario, Canada.
从国家住院样本来看,行经皮冠状动脉介入治疗的急性心肌梗死患者的有症状 HIV 感染和院内结局。
Sci Rep. 2024 Apr 29;14(1):9832. doi: 10.1038/s41598-024-59920-9.
4
Ten-year trends of clinical outcomes after percutaneous coronary intervention: a Korean nationwide longitudinal cohort study.经皮冠状动脉介入治疗后 10 年临床结局的趋势:一项韩国全国性纵向队列研究。
BMJ Open. 2022 Apr 20;12(4):e056972. doi: 10.1136/bmjopen-2021-056972.
5
Outcomes and regional differences in practice in a worldwide coronary stent registry.全球冠状动脉支架注册研究中的结果和实践的地区差异。
Heart. 2022 Jul 27;108(16):1310-1318. doi: 10.1136/heartjnl-2021-320116.
6
Sympathetic Activation and Arrhythmogenesis after Myocardial Infarction: Where Do We Stand?心肌梗死后的交感神经激活与心律失常发生机制:我们目前的进展如何?
J Cardiovasc Dev Dis. 2021 May 15;8(5):57. doi: 10.3390/jcdd8050057.
7
Current trends in optimal medical therapy after PCI and its influence on clinical outcomes in China.经皮冠状动脉介入治疗(PCI)后最佳药物治疗的现状及其对中国临床结局的影响。
BMC Cardiovasc Disord. 2021 May 26;21(1):258. doi: 10.1186/s12872-021-02052-z.
8
Retrospective cohort analysis of Spanish national trends of coronary artery bypass grafting and percutaneous coronary intervention from 1998 to 2017.1998年至2017年西班牙冠状动脉搭桥术和经皮冠状动脉介入治疗全国趋势的回顾性队列分析。
BMJ Open. 2021 Apr 7;11(4):e046141. doi: 10.1136/bmjopen-2020-046141.
9
The Mid-term Mortality and Mode of Death in Survivors with ST-elevation Myocardial Infarction.ST 段抬高型心肌梗死存活者的中期死亡率和死亡模式。
Intern Med. 2021 Jun 1;60(11):1665-1674. doi: 10.2169/internalmedicine.6549-20. Epub 2020 Dec 29.
利用加拿大安大略省的关联死亡记录研究移民和长期居民中全因、过早和可避免死亡的社会经济梯度。
J Epidemiol Community Health. 2017 Jul;71(7):625-632. doi: 10.1136/jech-2016-208525. Epub 2017 Mar 13.
4
Decline in Cardiovascular Mortality: Possible Causes and Implications.心血管疾病死亡率的下降:可能的原因及影响
Circ Res. 2017 Jan 20;120(2):366-380. doi: 10.1161/CIRCRESAHA.116.309115.
5
Cardiac and Noncardiac Causes of Long-Term Mortality in ST-Segment-Elevation Acute Myocardial Infarction Patients Who Underwent Primary Percutaneous Coronary Intervention.接受直接经皮冠状动脉介入治疗的ST段抬高型急性心肌梗死患者长期死亡的心脏和非心脏原因
Circ Cardiovasc Qual Outcomes. 2017 Jan;10(1). doi: 10.1161/CIRCOUTCOMES.116.002790.
6
Validity and utility of ICD-10 administrative health data for identifying ST- and non-ST-elevation myocardial infarction based on physician chart review.基于医生病历审查,ICD - 10管理性健康数据用于识别ST段抬高型和非ST段抬高型心肌梗死的有效性和实用性。
CMAJ Open. 2015 Oct 2;3(4):E413-8. doi: 10.9778/cmajo.20150060. eCollection 2015 Oct-Dec.
7
Mortality from Alzheimer's disease in Canada: A multiple-cause-of-death analysis, 2004 to 2011.加拿大阿尔茨海默病死亡率:2004 年至 2011 年多死因分析。
Health Rep. 2016 May 18;27(5):17-21.
8
Validity of Diagnostic Codes for Acute Stroke in Administrative Databases: A Systematic Review.行政数据库中急性卒中诊断编码的有效性:一项系统评价。
PLoS One. 2015 Aug 20;10(8):e0135834. doi: 10.1371/journal.pone.0135834. eCollection 2015.
9
Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial.经皮冠状动脉介入治疗的急性冠状动脉综合征患者中桡动脉与股动脉入路的随机多中心试验。
Lancet. 2015 Jun 20;385(9986):2465-76. doi: 10.1016/S0140-6736(15)60292-6. Epub 2015 Mar 16.
10
Short- and long-term cause of death in patients treated with primary PCI for STEMI.ST段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗的短期和长期死因。
J Am Coll Cardiol. 2014;64(20):2101-8. doi: 10.1016/j.jacc.2014.08.037. Epub 2014 Nov 10.